{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:34:53Z","timestamp":1793327693945,"version":"4.5.0"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health through Ricerca Corrente, Linea 3"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background: Vancomycin-resistant enterococci (VRE) rectal colonization represents a critical risk factor for subsequent bloodstream infections (BSIs), posing a serious concern in healthcare settings. This study aims to investigate the association between the presence of VRE in rectal swabs and the occurrence of BSIs, highlighting the challenges of rapid detection and patient care implications in an infectious disease hospital setting. Methods: We performed a retrospective analysis of cultural rectal swab screening and molecular assays (MAs) for VRE detection between January 2020 and December 2023. All adult patients admitted with at least one rectal swab screening performed during hospitalization were included. All blood cultures that yielded VRE were identified, and the first Enterococcus-positive blood sample for each patient with at least one prior rectal swab per year was analyzed. Results: The results showed a 15.4% positivity rate for VRE in cultural screening, predominantly Enterococcus faecium. MA showed a higher prevalence of 49.4%, with a significant discordance between MA rectal swab screening and cultural testing. Patients with VRE intestinal colonization by E. faecium were significantly more likely to develop E. faecium BSI, with a risk ratio of 9.78 (p &lt; 0.001). Conclusions: The study identified a strong correlation between VRE rectal colonization and the risk of developing BSI, emphasizing the need for effective screening and infection control measures. The results support the inclusion of molecular testing in VRE detection protocols and highlight the importance of ongoing surveillance for antimicrobial resistance.<\/jats:p>","DOI":"10.3390\/antibiotics14030304","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:49:57Z","timestamp":1742197797000},"page":"304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3662-4312","authenticated-orcid":false,"given":"Assunta","family":"Navarra","sequence":"first","affiliation":[{"name":"Clinical Epidemiology Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-6917","authenticated-orcid":false,"given":"Stefania","family":"Cicalini","sequence":"additional","affiliation":[{"name":"Systemic and Immune Depression-Associated Infections Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-6194","authenticated-orcid":false,"given":"Silvia","family":"D\u2019Arezzo","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7899-889X","authenticated-orcid":false,"given":"Francesca","family":"Pica","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9131-7502","authenticated-orcid":false,"given":"Marina","family":"Selleri","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-0437","authenticated-orcid":false,"given":"Carla","family":"Nisii","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2644-1862","authenticated-orcid":false,"given":"Carolina","family":"Venditti","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-2127","authenticated-orcid":false,"given":"Angela","family":"Cannas","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-4368","authenticated-orcid":false,"given":"Antonio","family":"Mazzarelli","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0023-9658","authenticated-orcid":false,"given":"Antonella","family":"Vulcano","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-1026","authenticated-orcid":false,"given":"Stefania","family":"Carrara","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Vincenti","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-3996","authenticated-orcid":false,"given":"Barbara","family":"Bartolini","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Giacomini","sequence":"additional","affiliation":[{"name":"Health Direction, Hospital Information Service, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-8442","authenticated-orcid":false,"given":"Maria Grazia","family":"Bocci","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2198-1947","authenticated-orcid":false,"given":"Carla","family":"Fontana","sequence":"additional","affiliation":[{"name":"Microbiology and Biobank Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d, IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0053-2018","article-title":"Pathogenicity of Enterococci","volume":"7","author":"Fiore","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/viru.21282","article-title":"Intrinsic and acquired resistance mechanisms in Enterococcus","volume":"3","author":"Hollenbeck","year":"2012","journal-title":"Virulence"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.mib.2010.08.004","article-title":"Horizontal gene transfer and the genomics of enterococcal antibiotic resistance","volume":"13","author":"Palmer","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_4","unstructured":"ECDC\/WHO European Region (2025, January 03). Surveillance of Antimicrobial Resistance in Europe, 2023 Data. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2023-data-executive-summary."},{"key":"ref_5","unstructured":"European Centre for Disease Prevention and Control (2024). Antimicrobial Resistance in the EU\/EEA (EARS-Net)\u2014Annual Epidemiological Report 2023, ECDC. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report-2023."},{"key":"ref_6","unstructured":"Iacchini, S., Boros, S., Pezzotti, P., Errico, G., Del Grosso, M., Camilli, R., Giufr\u00e8, M., Pantosti, A., Maraglino, F., and Palamara, A.T. (2024, November 20). AR-ISS: Sorveglianza Nazionale dell\u2019Antibiotico-Resistenza. Dati 2023. Rapp. ISS 2024, Sorveglianza RIS 5\/2024. Available online: https:\/\/www.epicentro.iss.it\/antibiotico-resistenza\/ar-iss\/RIS-5_2024.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00134-021-06346-w","article-title":"COVID-19 increased the risk of ICU-acquired bloodstream infections: A case-cohort study from the multicentric OUTCOMEREA network","volume":"47","author":"Buetti","year":"2021","journal-title":"Int. Care Med."},{"key":"ref_8","first-page":"e31","article-title":"Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study","volume":"49","author":"Bonazzetti","year":"2021","journal-title":"Int. Care Med."},{"key":"ref_9","first-page":"115","article-title":"Evaluating the Trend of VRE carriages in Health Facilities: A Retrospective Study from 2019-2022","volume":"36","author":"Cremona","year":"2024","journal-title":"Ann. Di Ig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/infdis\/jiv597","article-title":"Gastrointestinal Tract Colonization Dynamics by Different Enterococcus faecium Clades","volume":"213","author":"Montealegre","year":"2016","journal-title":"J. Infect Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/ice.2017.248","article-title":"Vancomycin-Resistant Enterococci (VRE) in The Intensive Care Unit in a Nonoutbreak Setting: Identification of Potential Reservoirs and Epidemiological Associations Between Patient and Environmental VRE","volume":"39","author":"McDermott","year":"2018","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13756-023-01332-x","article-title":"Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: A matched case-control study","volume":"12","author":"Meschiari","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bjid.2014.09.010","article-title":"Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci","volume":"19","author":"Kara","year":"2015","journal-title":"Braz. J. Infect. Dis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.9778\/cmajo.20170034","article-title":"Predictive utility of swab screening for vancomycin-resistant Enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: A retrospective cohort study","volume":"5","author":"Brasg","year":"2017","journal-title":"CMAJ Open"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/JLP.JLP_32_17","article-title":"Risk factors for intestinal colonization with vancomycin-resistant enterococci\u2019 A prospective study in a level III pediatric intensive care unit","volume":"10","author":"Amberpet","year":"2018","journal-title":"J. Lab. Physicians"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10096-024-04987-5","article-title":"Rectal colonization with multidrug-resistant organisms and risk for bloodstream infection among high-risk Greek patients","volume":"44","author":"Karakosta","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/ice.2019.380","article-title":"Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia","volume":"41","author":"Cheng","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1017\/ash.2021.215","article-title":"Impact of a vancomycin-resistant Enterococcus (VRE) screening result on appropriateness of antibiotic therapy","volume":"1","author":"Reynolds","year":"2021","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diagmicrobio.2017.08.009","article-title":"Two-tier approach combining molecular and culture-based techniques for optimized detection of vancomycin-resistant enterococci","volume":"89","author":"Both","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zakaria, N.D., Hamzah, H.H., Salih, I.L., Balakrishnan, V., and Abdul Razak, K. (2023). A Review of Detection Methods for Vancomycin-Resistant Enterococci (VRE) Genes: From Conventional Approaches to Potentially Electrochemical DNA Biosensors. Biosensors, 13.","DOI":"10.3390\/bios13020294"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/JCM.41.10.4805-4807.2003","article-title":"Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococci","volume":"41","author":"Paule","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Correa-Martinez, C.L., T\u00f6nnies, H., Frob\u00f6se, N.J., Mellmann, A., and Kampmeier, S. (2020). Transmission of Vancomycin-Resistant Enterococci in the Hospital Setting: Uncovering the Patient-Environment Interplay. Microorganisms, 8.","DOI":"10.3390\/microorganisms8020203"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","article-title":"The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: An epidemiological analysis of bloodstream infections","volume":"9","author":"Ayobami","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13756-023-01278-0","article-title":"Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: A scoping review comparing the epidemiology in the Netherlands and Germany","volume":"12","author":"Cimen","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jmii.2022.08.003","article-title":"Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed","volume":"55 (6 Pt 2)","author":"Fukushige","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_26","first-page":"DC06","article-title":"Screening for Intestinal Colonization with Vancomycin Resistant Enterococci and Associated Risk Factors among Patients Admitted to an Adult Intensive Care Unit of a Large Teaching Hospital","volume":"10","author":"Amberpet","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1017\/ice.2020.1218","article-title":"A rectal swab screening as a predictor of subsequent vancomycin-resistant enterococcal bloodstream infection in critically ill adults","volume":"42","author":"Kram","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(22)00811-8","article-title":"Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: A systematic review and meta-regression analysis","volume":"23","author":"Willems","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"ofae712","DOI":"10.1093\/ofid\/ofae712","article-title":"Long-term Risk of Infection Among Patients Colonized with Antimicrobial-Resistant Pathogens: A Population-wide Cohort Study","volume":"11","author":"Blagojevic","year":"2024","journal-title":"Open Forum. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1099\/jmm.0.029777-0","article-title":"Evaluation of PCR-based screening for vancomycin-resistant enterococci compared with a chromogenic agar-based culture method","volume":"60","author":"Seo","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(00)04206-9","article-title":"Enterococcal vanB resistance locus in anaerobic bacteria in human faeces","volume":"357","author":"Stinear","year":"2001","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kling, K., Rios, J., Dirnberger, L., Polanco, W., Fritz, K., Malczynski, M., Zembower, T., and Qi, C. (2023). Development of a workflow for the detection of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from rectal swabs using the spectra VRE medium. Ann. Clin. Microbiol. Antimicrob., 22.","DOI":"10.1186\/s12941-023-00552-8"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10096-024-04768-0","article-title":"Genetic analysis of vancomycin-variable Enterococcus faecium clinical isolates in Italy","volume":"43","author":"Coccitto","year":"2024","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lee, S.Y., Nam, J.-H., Kim, J.W., Kim, S.H., and Yoo, J.S. (2024). Prevalence of Vancomycin-Variable Enterococci from the Bloodstream in the Korea Global Antibiotic Resistance Surveillance System, 2017\u20132022. Antibiotics, 13.","DOI":"10.3390\/antibiotics13121210"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cmi.2020.04.027","article-title":"Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: A EUCAST position paper","volume":"26","author":"Turnidge","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_36","unstructured":"(2020, January 02). The European Committee on Antimicrobial Susceptibility Testing (EUCAST): 2020 Version 10.0 Clinical Breakpoints and Dosing of Antibiotics. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_10.0_Breakpoint_Tables.pdf."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Echeverr\u00eda-Esnal, D., Sorli, L., Prim, N., Martin-Ontiyuelo, C., Horcajada, J.P., and Grau, S. (2021). Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10060716"},{"key":"ref_38","unstructured":"(2021, January 05). The European Committee on Antimicrobial Susceptibility Testing (EUCAST): 2021 Version 11.0 Clinical Breakpoints and Dosing of Antibiotics. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_11.0_Breakpoint_Tables.pdf."},{"key":"ref_39","unstructured":"(2022, January 01). The European Committee on Antimicrobial Susceptibility Testing (EUCAST): 2022 Version 12.0 Clinical Breakpoints and Dosing of Antibiotics. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_12.0_Breakpoint_Tables.pdf."},{"key":"ref_40","unstructured":"(2023, January 05). The European Committee on Antimicrobial Susceptibility Testing (EUCAST): 2023 Version 13.1 Clinical Breakpoints and Dosing of Antibiotics. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_13.1_Breakpoint_Tables.pdf."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/3\/304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:54:31Z","timestamp":1760028871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/3\/304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,16]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["antibiotics14030304"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14030304","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,16]]}}}